MEDICINES Citation, commencement and interpretation 1 1 This Order may be cited as the Prescription Only Medicines (Human Use) Amendment Order 2000 and shall come into force on 9th August 2000. 2 In this Order, “the principal Order ” means the Prescription Only Medicines (Human Use) Order 1997 . Amendments of the principal Order with respect to sale and supply by hospitals and national health service bodies 2 The principal Order is amended as follows— a in paragraph (2) of article 1 of the principal Order, there is inserted, at the appropriate place in the alphabetical order of the entries in that paragraph, the following entries— “Common Services Agency” means the Common Services Agency for the Scottish Health Service established under section 10 of the National Health Service (Scotland) Act 1978 ; “Community marketing authorization” means a marketing authorization granted by the European Community under Council Regulation ( EEC ) No. 2309/93 ; “Health Authority”— in relation to England and Wales, has the same meaning as in the National Health Service Act 1977 ; in relation to Scotland, means a Health Board constituted under section 2 of the National Health Service (Scotland) Act 1978; and in relation to Northern Ireland, means a Health and Social Services Board established under Article 16 of the Health and Personal Social Services (Northern Ireland) Order 1972 ; “homoeopathic certificate of registration” means a certificate of registration for the purposes of the Medicines (Homoeopathic Medicinal Products For Human Use) Regulations 1994 ; “marketing authorization” includes a reference both to a United Kingdom marketing authorization and to a Community marketing authorization; “ NHS trust”— in relation to England and Wales, has the same meaning as in the National Health Service and Community Care Act 1990 ; in relation to Scotland, has the same meaning as in the National Health Service (Scotland) Act 1978; and in relation to Northern Ireland, means a Health and Social Services trust established under article 10 of the Health and Social Services (Northern Ireland) Order 1991 ; “Patient Group Direction” means— in connection with the supply of a prescription only medicine as referred to in article 12A(2), 12B or 12C, a written direction relating to the supply and administration of a description or class of prescription only medicine; or in connection with the administration of a prescription only medicine as referred to in article 12A(2), 12B or 12C, a written direction relating to the administration of a description or class of prescription only medicine, and which, in the case of either (a) or (b)— is signed by a doctor or dentist, and by a pharmacist; and relates to supply and administration, or to administration, to persons generally (subject to any exclusions which may be set out in the Direction); “Primary Care Trust” has the same meaning as in the National Health Service Act 1977 ; “Special Health Authority”— in relation to England and Wales, has the same meaning as in the National Health Service Act 1977 ; in relation to Scotland, means a Special Health Board constituted under section 2 of the National Health Service (Scotland) Act 1978; and in relation to Northern Ireland, means a Special Health and Social Services Agency established under the Health and Personal Social Services (Special Agencies) (Northern Ireland) Order 1990 ; “state registered paramedic” means a person who is registered in the register established and maintained under section 2(1) of the Professions Supplementary to Medicine Act 1960 by the Paramedics Board ; “United Kingdom marketing authorization” means a marketing authorization granted by the licensing authority under the Medicines For Human Use (Marketing Authorisations Etc.) Regulations 1994 (including a product licence having effect as such an authorization by virtue of Schedule 6 to those Regulations) . ; b in article 1 of the principal Order, after paragraph (6), there is added— 7 In articles 12 to 12C, a reference to a prescription only medicine being sold or supplied for the purpose of being administered in accordance with the written directions of a doctor or dentist relating to a particular person, or in accordance with a Patient Group Direction, includes a reference to it being sold or supplied in accordance with such directions or such a Direction. 8 In articles 12A and 12C, a reference to an arrangement for the supply or adminstration of prescription only medicines includes a reference to an arrangement which covers such supply or administration and other matters. 9 In Schedule 7, Part I, a reference to treatment of a clinical situation includes a reference to any form of management of that situation. ; c for article 12 of the principal Order, there is substituted— Exemption for sale or supply in hospitals 12 The restrictions imposed by section 58(2)(a) (restrictions on sale and supply) shall not apply to the sale or supply of a prescription only medicine in the course of the business of a hospital where the medicine is sold or supplied for the purpose of being administered (whether in the hospital or elsewhere) to a particular person in accordance with the written directions of a doctor or dentist relating to that person notwithstanding that those directions do not satisfy the conditions specified in article 15(2). ; d after article 12 of the principal Order, there is inserted— Exemptions for the supply and administration of prescription only medicines by national health service bodies 12A 1 The restrictions imposed by section 58(2)(a) (restrictions on sale and supply) shall not apply to the supply of a prescription only medicine by— a the Common Services Agency; b a Health Authority or Special Health Authority; c an NHS trust; d a Primary Care Trust; or e where sub-paragraphs (a) to (d) do not apply, a person other than an excepted person, pursuant to an arrangement made with one of the persons specified in those sub-paragraphs for the supply of prescription only medicines, where the medicine is supplied for the purpose of being administered to a particular person in accordance with the written directions of a doctor or dentist relating to that person notwithstanding that those directions do not satisfy the conditions specified in article 15(2). 2 The restrictions imposed by section 58(2) (restrictions on sale, supply and administration) shall not apply to the supply or, as the case may be, the administration of a prescription only medicine by— a the Common Services Agency; b a Health Authority or Special Health Authority; c an NHS trust; d a Primary Care Trust; or e where sub-paragraphs (a) to (d) do not apply, a person other than an excepted person, pursuant to an arrangement made with one of the persons specified in those sub-paragraphs for the supply or, as the case may be, the administration of prescription only medicines, where the medicine is supplied for the purpose of being administered, or, as the case may be, is administered, to a particular person in accordance with a Patient Group Direction and where the conditions specified in paragraph (3) are satisfied. 3 The conditions referred to are that— a the Patient Group Direction relates to the supply or, as the case may be, the administration, by the person who supplies or administers the medicine, of a description or class of prescription only medicine, and the Direction has effect at the time at which the medicine is supplied or, as the case may be, is administered; b the Patient Group Direction contains the particulars specified in Part I of Schedule 7 to this Order (but with the omission of paragraph (c) of that Part in the case of a Direction which relates to administration only); c the Patient Group Direction is signed on behalf of the person specified in column 2 of the Table in Part II of Schedule 7 to this Order (“the authorising person”) against the entry in column 1 of that Table for the class of person by whom the medicine is supplied or administered; d the individual who supplies or, as the case may be, administers the medicine belongs to one of the classes of individual specified in Part III of Schedule 7 to this Order, and is designated in writing, on behalf of the authorising person, for the purpose of the supply or, as the case may be, the administration of prescription only medicines under the Patient Group Direction; and e at the time at which the medicine is supplied or, as the case may be, is administered, a product licence, a marketing authorization or a homoeopathic certificate of registration has effect in respect of it. 4 In this article, “excepted person” means— a a doctor or dentist; or b a person lawfully conducting a retail pharmacy business within the meaning of section 69. Exemption for health professionals who supply or administer prescription only medicines under a Patient Group Direction in order to assist doctors or dentists in providing national health services 12B 1 The restrictions imposed by section 58(2) (sale, supply and administration) shall not apply to the supply or, as the case may be, the administration of a prescription only medicine by an individual belonging to one of the classes specified in Part III of Schedule 7 to this Order where— a the individual supplies or, as the case may be, administers the medicine in order to assist a doctor or dentist in the provision of, respectively, NHS primary medical services or NHS primary dental services; b the medicine is supplied for the purpose of being administered, or, as the case may be, is administered, in accordance with a Patient Group Direction; and c the conditions specified in paragraph (2) are satisfied. 2 The conditions referred to are that— a the Patient Group Direction relates to the supply or, as the case may be, the administration of a description or class of prescription only medicine in order to assist the doctor or dentist in question in providing the services referred to in paragraph (1)(a) (whether or not it also relates to such supply or administration in order to assist any other doctor or dentist); b the Patient Group Direction has effect at the time at which the medicine is supplied or, as the case may be, is administered; c the Patient Group Direction contains the particulars specified in Part I of Schedule 7 to this Order (but with the omission of paragraph (c) of that Part in the case of a Direction which relates to administration only); d the Patient Group Direction is signed— i by the doctor or dentist in question or, alternatively, where the Direction also relates to supply or administration in order to assist one or more other doctors or dentists, as referred to in sub-paragraph (a), by one of those other doctors or dentists; and ii on behalf of the health authority— a in the case of the provision of general medical services or general dental services, with which an arrangement has been made for the provision of those services; or b in the case of the performance of personal medical services or personal dental services, which is a party to the pilot scheme under which those services are provided; e the individual referred to in paragraph (1) is designated in writing for the purpose of the supply or, as the case may be, the administration of prescription only medicines under the Patient Group Direction, by the doctor or dentist in question, or, alternatively, where the Direction also relates to supply or administration in order to assist one or more other doctors or dentists, as referred to in sub-paragraph (a), by one of those other doctors or dentists; and f at the time at which the medicine is supplied or, as the case may be, is administered, a product licence, a marketing authorization or a homoeopathic certificate of registration has effect in respect of it. 3 In this article— a a reference to the provision of NHS primary dental services shall be construed as a reference to— i in relation to England and Wales, the provision of general dental services under Part II of the National Health Service Act 1977, or the performance of personal dental services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997 ; ii in relation to Scotland, the provision of general dental services under Part II of the National Health Service (Scotland) Act 1978, or the performance of personal dental services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997; and iii in relation to Northern Ireland, the provision of general dental services under the Health and Personal Social Services (Northern Ireland) Order 1972 , or the performance of personal dental services in connection with a pilot scheme under the Health Services (Primary Care) (Northern Ireland) Order 1997 ; b a reference to the provision of NHS primary medical services shall be construed as a reference to— i in relation to England and Wales, the provision of general medical services under Part II of the National Health Service Act 1977, or the performance of personal medical services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997; ii in relation to Scotland, the provision of general medical services under Part II of the National Health Service (Scotland) Act 1978, or the performance of personal medical services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997; and iii in relation to Northern Ireland, the provision of general medical services under the Health and Personal Social Services (Northern Ireland) Order 1972, or the performance of personal medical services in connection with a pilot scheme under the Health Services (Primary Care) (Northern Ireland) Order 1997. Exemption for persons conducting a retail pharmacy business who supply or administer prescription only medicines under a Patient Group Direction 12C 1 The restrictions imposed by section 58(2) (restrictions on sale, supply and administration) shall not apply to the supply or, as the case may be, the administration of a prescription only medicine by a person lawfully conducting a retail pharmacy business within the meaning of section 69 where— a the medicine is supplied or, as the case may be, is administered by such a person pursuant to an arrangement made with the Common Services Agency, a Health Authority, a Special Health Authority, an NHS trust or a Primary Care Trust for the supply or, as the case may be, the administration of prescription only medicines; b the medicine is supplied for the purpose of being administered, or, as the case may be, is administered, to a particular person in accordance with a Patient Group Direction; and c the conditions specified in paragraph (2) are satisfied. 2 The conditions referred to are that— a the Patient Group Direction relates to the supply or, as the case may be, the administration of a description or class of prescription only medicine by the person lawfully conducting a retail pharmacy business who supplies or, as the case may be, administers the prescription only medicine, and the Direction has effect at the time at which the medicine is supplied or, as the case may be, is administered; b the Patient Group Direction contains the particulars specified in Part I of Schedule 7 to this Order (but with the omission of paragraph (c) of that Part in the case of a Direction which relates to administration only); c the Patient Group Direction is signed on behalf of the body with which an arrangement has been made as referred to in paragraph (1)(a); and d at the time at which the medicine is supplied or, as the case may be, is administered, a product licence, a marketing authorization or a homoeopathic certificate of registration has effect in respect of it. ; and e after Schedule 6 to the principal Order, there is inserted— SCHEDULE 7 Articles 12A to 12C PART I PARTICULARS TO BE INCLUDED IN A PATIENT GROUP DIRECTION a the period during which the Direction shall have effect; b the description or class of prescription only medicine to which the Direction relates; c whether there are any restrictions on the quantity of medicine which may be supplied on any one occasion, and, if so, what restrictions; d the clinical situations which prescription only medicines of that description or class may be used to treat; e the clinical criteria under which a person shall be eligible for treatment; f whether any class of person is excluded from treatment under the Direction and, if so, what class of person; g whether there are circumstances in which further advice should be sought from a doctor or dentist and, if so, what circumstances; h the pharmaceutical form or forms in which prescription only medicines of that description or class are to be administered; i the strength, or maximum strength, at which prescription only medicines of that description or class are to be administered; j the applicable dosage or maximum dosage; k the route of administration; l the frequency of administration; m any minimum or maximum period of administration applicable to prescription only medicines of that description or class; n whether there are any relevant warnings to note, and, if so, what warnings; o whether there is any follow up action to be taken in any circumstances, and, if so, what action and in what circumstances; p arrangements for referral for medical advice; q details of the records to be kept of the supply, or the administration, of medicines under the Direction. PART II PERSONS ON WHOSE BEHALF A PATIENT GROUP DIRECTION MUST BE SIGNED Column 1 Column 2 Class of person by whom a prescription only medicine is supplied or administered Person on whose behalf the Direction must be signed Common Services Agency The Agency Health Authority The Health Authority Special Health Authority The Special Health Authority NHS trust The trust Primary Care Trust The Trust A person who supplies or administers a prescription only medicine pursuant to an arrangement made with the Common Services Agency, a Health Authority, a Special Health Authority, an NHS trust or a Primary Care Trust The Common Services Agency, where the arrangement has been made with the Agency; or the Health Authority, Special Health Authority, NHS trust or Primary Care Trust with which the arrangement has been made PART III CLASSES OF INDIVIDUAL BY WHOM SUPPLIES MAY BE MADE Individuals who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State, or individuals who are state registered paramedics. Pharmacists. Registered health visitors . Registered midwives. Registered nurses. Registered ophthalmic opticians. State registered chiropodists. Individuals who are registered in the register established and maintained under section 2(1) of the Professions Supplementary to Medicine Act 1960 by the Orthoptists Board (state registered orthoptists) . Individuals who are registered in the register established and maintained under section 2(1) of the Professions Supplementary to Medicine Act 1960 by the Physiotherapists Board (state registered physiotherapists). Individuals who are registered in the register established and maintained under section 2(1) of the Professions Supplementary to Medicine Act 1960 by the Radiographers Board (state registered radiographers). . Amendment of Schedule 1 to the principal Order concerning specified substances and exemptions from the restrictions on sale and supply 3 In Schedule 1 to the principal Order (which specifies substances which, if included in medicinal products, make those products prescription only medicines, and exemptions from the restrictions on sale and supply of prescription only medicines)— a in relation to the substance Ibuprofen, there are inserted the following entries— in column 2— 3 10.0 per cent , in column 3— 3 External , in column 4— 3 125 mg (MD) 500 mg (MDD) , and in column 5— 3 Container or package containing not more than 100 g of medicinal product ; b there is inserted in column 1, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and, against that entry there is inserted in columns 2, 3 and 5 the corresponding entries in columns 2, 3 and 5 below— Column 1 Column 2 Column 3 Column 5 Substance Maximum strength Use, pharmaceutical form or route of administration Maximum quantity Terbinafine Hydrochloride 1.0 per cent External use for the treatment of tinea pedis and tinea cruris Container or package containing not more than 15 g of medicinal product. ; and c there is inserted in column 1, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the following substances— “Acamprosate” “Aceclofenac” “Alendronate Sodium” “Anastrozole” “Didanosine” “Eformoterol Fumarate” “Imidapril Hydrochloride” “Mirtazapine” “Moxonidine” “Omeprazole Magnesium” “Ranitidine Bismuth Citrate” “Rimexolone” “Sertraline Hydrochloride” “Sevoflurane” “Tazarotene” “Topiramate”. Signed by authority of the Secretary of State for Health Hunt Parliamentary Under Secretary of State, Department of Health 15th July 2000 Bairbre de Brún Minister of Health, Social Services and Public Safety 17th July 2000